IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $503 | +11.5% | 11,096 | +1.0% | 0.04% | +5.6% |
| Q2 2023 | $451 | +11.1% | 10,988 | -3.4% | 0.04% | +20.0% |
| Q1 2023 | $406 | -4.7% | 11,372 | +0.9% | 0.03% | -14.3% |
| Q4 2022 | $426 | -99.9% | 11,272 | +10.8% | 0.04% | -16.7% |
| Q3 2022 | $450,000 | -3.4% | 10,170 | -19.3% | 0.04% | 0.0% |
| Q2 2022 | $466,000 | +50.8% | 12,597 | +51.2% | 0.04% | +320.0% |
| Q1 2022 | $309,000 | – | 8,334 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |